These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8722499)
21. Interactions between serotoninergic and aminoacidergic pathways in the control of PRL secretion in prepubertal male rats. Pinilla L; González LC; Tena-Sempere M; Aguilar E J Physiol Biochem; 2001 Sep; 57(3):237-44. PubMed ID: 11800286 [TBL] [Abstract][Full Text] [Related]
22. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus. Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325 [TBL] [Abstract][Full Text] [Related]
23. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. Sánchez C; Hyttel J Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161 [TBL] [Abstract][Full Text] [Related]
24. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635. Fornal CA; Martin FJ; Metzler CW; Jacobs BL J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Barton CL; Hutson PH Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679 [TBL] [Abstract][Full Text] [Related]
26. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice. Darmani NA; Reeves SL Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031 [TBL] [Abstract][Full Text] [Related]
27. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration. Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067 [TBL] [Abstract][Full Text] [Related]
28. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo. Rollema H; Clarke T; Sprouse JS; Schulz DW J Neurochem; 1996 Nov; 67(5):2204-7. PubMed ID: 8863532 [TBL] [Abstract][Full Text] [Related]
29. Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex. Shalom G; Gur E; Van de Kar LD; Newman ME Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):84-90. PubMed ID: 15309378 [TBL] [Abstract][Full Text] [Related]
30. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Gobert A; Millan MJ Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475 [TBL] [Abstract][Full Text] [Related]
31. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat. Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364 [TBL] [Abstract][Full Text] [Related]
32. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats. Zhou FC; McKinzie DL; Patel TD; Lumeng L; Li TK Alcohol Clin Exp Res; 1998 Feb; 22(1):266-9. PubMed ID: 9514317 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output. van Amsterdam C; Seyfried CA Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272 [TBL] [Abstract][Full Text] [Related]
34. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. Wada Y; Hirao N; Shiraishi J; Nakamura M; Koshino Y Neurosci Lett; 1999 May; 267(1):61-4. PubMed ID: 10400249 [TBL] [Abstract][Full Text] [Related]
35. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test. Gigliucci V; Buckley KN; Nunan J; O'Shea K; Harkin A Pharmacol Biochem Behav; 2010 Feb; 94(4):524-33. PubMed ID: 19945477 [TBL] [Abstract][Full Text] [Related]
36. Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice. Artaiz I; Zazpe A; Del Río J Behav Pharmacol; 1998 Mar; 9(2):103-12. PubMed ID: 10065930 [TBL] [Abstract][Full Text] [Related]
37. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine. Li XM; Perry KW; Wong DT Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599 [TBL] [Abstract][Full Text] [Related]
38. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists. Trillat AC; Malagié I; Mathe-Allainmat M; Anmella MC; Jacquot C; Langlois M; Gardier AM Eur J Pharmacol; 1998 Sep; 357(2-3):179-84. PubMed ID: 9797034 [TBL] [Abstract][Full Text] [Related]
40. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. Knobelman DA; Hen R; Lucki I J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]